Information  X 
Enter a valid email address

GlaxoSmithKline PLC (GSK)

  Print      Mail a friend       Annual reports

Tuesday 02 April, 2013

GlaxoSmithKline PLC

Total Voting Rights

RNS Number : 3307B
GlaxoSmithKline PLC
02 April 2013









Total Voting Rights and Capital


In conformity with Disclosure and Transparency Rule 5.6.1R, GlaxoSmithKline plc (the Company) hereby notifies the market of the following:


The Company's issued share capital as at 28 March 2013 consisted of 5,407,676,569 Ordinary Shares of 25p each, of which 498,081,327 Ordinary Shares were held in Treasury.


Therefore, the total number of voting rights in the Company is 4,909,595,242. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Services Authority's Disclosure and Transparency Rules.




V A Whyte

Company Secretary


2 April 2013



This information is provided by RNS
The company news service from the London Stock Exchange

a d v e r t i s e m e n t